42:I[185,["/_next/static/chunks/3xnt26d00_zk-.js","/_next/static/chunks/0gtn0si1crxii.js","/_next/static/chunks/42spz6paskvb6.js","/_next/static/chunks/06x30xgfe6iur.js","/_next/static/chunks/1pfyc3q3c61jb.js","/_next/static/chunks/35-gbipsuw5b6.js"],"SendEmailButton"] 44:I[63625,["/_next/static/chunks/3xnt26d00_zk-.js","/_next/static/chunks/0gtn0si1crxii.js","/_next/static/chunks/42spz6paskvb6.js","/_next/static/chunks/06x30xgfe6iur.js","/_next/static/chunks/1pfyc3q3c61jb.js","/_next/static/chunks/35-gbipsuw5b6.js"],"AddToLibraryButton"] 45:I[29721,["/_next/static/chunks/3xnt26d00_zk-.js","/_next/static/chunks/0gtn0si1crxii.js","/_next/static/chunks/42spz6paskvb6.js","/_next/static/chunks/06x30xgfe6iur.js","/_next/static/chunks/1pfyc3q3c61jb.js","/_next/static/chunks/35-gbipsuw5b6.js"],"ShareButton"] 46:I[58016,["/_next/static/chunks/3xnt26d00_zk-.js","/_next/static/chunks/0gtn0si1crxii.js","/_next/static/chunks/42spz6paskvb6.js","/_next/static/chunks/06x30xgfe6iur.js","/_next/static/chunks/1pfyc3q3c61jb.js","/_next/static/chunks/35-gbipsuw5b6.js"],"ProcessEpisodeButton"] 47:I[45269,["/_next/static/chunks/3xnt26d00_zk-.js","/_next/static/chunks/0gtn0si1crxii.js","/_next/static/chunks/42spz6paskvb6.js","/_next/static/chunks/06x30xgfe6iur.js","/_next/static/chunks/1pfyc3q3c61jb.js","/_next/static/chunks/35-gbipsuw5b6.js"],"SignupCTA"] 3b:["$","h1",null,{"className":"max-w-[22ch] font-display text-[clamp(32px,4.5vw,48px)] font-medium leading-[1.05] tracking-[-0.02em] text-[color:var(--fg-1)] text-balance","children":"How Medtech Startups Can Scale Smarter with Chris Kennedy, Vice President of Partnerships at Prolucid Technologies"}] 3c:["$","div",null,{"className":"flex flex-wrap items-center gap-x-4 gap-y-1 font-mono text-[12px] uppercase tracking-[0.1em] text-[color:var(--fg-3)]","children":[["$","time",null,{"dateTime":"2026-05-05T10:00:00.000Z","children":"May 5, 2026"}],["$","span",null,{"aria-hidden":true,"children":"·"}],["$","span",null,{"children":"00:06:42"}],false]}] 43:T54f,

A breakthrough idea isn’t enough in medtech; it takes the right technical partner to navigate software, regulation, and the path to market.

In this episode, Chris Kennedy, Vice President of Partnerships at Prolucid Technologies, explains how the company helps medtech innovators transform complex ideas into market-ready products through specialized software engineering. He outlines Prolucid’s work across device software, software-as-a-medical-device, cloud applications, and FDA-regulated development. Chris highlights how they support founders in navigating challenges like design controls, cybersecurity, quality systems, and regulatory readiness. He also shares insights from MedTech Innovator, emphasizing the value of coachability and the growing role of AI as a force multiplier to help small teams scale efficiently.

Tune in to learn how medtech companies can build smarter, move faster, and use the right partnerships and tools to scale innovation more effectively.

Resources:Connect with and follow Chris Kennedy on LinkedIn.Follow Prolucid Technologies on LinkedIn and explore their website here.